Genomic Surveillance for Monitoring Variants of Concern: SARS-CoV-2 Delta, Omicron, and Beyond
Author:
- 16 July 2022
- book chapter
- Published by Springer Nature
- Vol. 2511, 407-413
Abstract
The continuing emergence of new SARS-CoV-2 variants has perpetuated the current pandemic far beyond initial expectations. It is now likely that this virus is here to stay. Thus, a new infrastructure is required for monitoring and tracking of viral outbreaks which includes epidemiological and genomic surveillance. More effective monitoring will support rapid response times required for development of new treatments and vaccines to help manage the spread of the current virus and prepare the platforms required for future pandemics. Key words COVID-19 SARS-CoV-2 Variant of concern qPCR Genomic surveillance VaccinationKeywords
This publication has 18 references indexed in Scilit:
- Coronavirus biology and replication: implications for SARS-CoV-2Nature Reviews Microbiology, 2020
- The coronavirus is mutating — does it matter?Nature, 2020
- A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final CappingCells, 2020
- Are we prepared for the next influenza pandemic? Lessons from modelling different preparedness policies against four pandemic scenariosJournal of Theoretical Biology, 2019
- Centennial review of influenza in TaiwanBiomedical Journal, 2018
- Next-Generation Sequencing: From Basic Research to DiagnosticsClinical Chemistry, 2009
- A new class of cleavable fluorescent nucleotides: synthesis and optimization as reversible terminators for DNA sequencing by synthesis †Nucleic Acids Research, 2008
- BTA, a novel reagent for DNA attachment on glass and efficient generation of solid-phase amplified DNA coloniesNucleic Acids Research, 2006
- Influenza Pandemics: Past, Present and FutureJournal of the Formosan Medical Association, 2006
- Mutation detection using fluorescent hybridization probes and melting curve analysisExpert Review of Molecular Diagnostics, 2001